Cite
HARVARD Citation
Dziadziuszko, R. et al. (2022). Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinib. Molecular oncology. 16 (10), pp. 2000-2014. [Online].